Safety and efficacy of galcanezumab in chronic and episodic migraine patients: a systematic review and meta-analysis of randomized controlled trials

Background The humanized monoclonal antibody galcanezumab is an anti-calcitonin-gene-related-peptide (CGRP) and frequently used for migraine prevention. However, the literature revealed limited data with conflicting results. This study aims to assess the safety and efficacy of galcanezumab in treati...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The Egyptian Journal of Neurology, Psychiatry and Neurosurgery Psychiatry and Neurosurgery, 2024-05, Vol.60 (1), p.60-15, Article 60
Hauptverfasser:	Zaazouee, Mohamed Sayed, Ebrahim, Rokaya Y., Al-araj, Ghaida’a, Zaki, Ibram, Saad, Ahmed, Farhat, Abdullah Mohamed, Ali, Mustafa Hussein, Elshennawy, Mohamed, Fawy, Omar Khaled Fahmy, Ahmed, Hadi F., Alahmad, Ziad, Nada, Eman Ayman, Abo-Hamra, Reem I., Elsnhory, Ahmed Bostamy, Eleyan, Mohammed, AbuEl-Enien, Hazem, Elromely, Rasha Abdo, AbdelQadir, Yossef Hassan, Shah, Jaffer, Elshanbary, Alaa Ahmed
Format:	Artikel
Sprache:	eng
Schlagworte:	Clinical trials Galcanezumab Headache LY2951742 Medicine Medicine & Public Health Meta-analysis Migraine Monoclonal antibodies Neurology Neurosurgery Psychiatry Response rates Review Systematic review
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!